2020

1. Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

   Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 8, pp. 1534-1542